Your browser doesn't support javascript.
loading
Protein O-GlcNAcylation and cardiovascular (patho)physiology.
Marsh, Susan A; Collins, Helen E; Chatham, John C.
Afiliação
  • Marsh SA; From the Section of Experimental and Systems Pharmacology, College of Pharmacy, Washington State University, Spokane, Washington 99210-1495 and.
  • Collins HE; the Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama 35294-0019.
  • Chatham JC; the Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama 35294-0019 jchatham@uab.edu.
J Biol Chem ; 289(50): 34449-56, 2014 Dec 12.
Article em En | MEDLINE | ID: mdl-25336635
Our understanding of the role of protein O-GlcNAcylation in the regulation of the cardiovascular system has increased rapidly in recent years. Studies have linked increased O-GlcNAc levels to glucose toxicity and diabetic complications; conversely, acute activation of O-GlcNAcylation has been shown to be cardioprotective. However, it is also increasingly evident that O-GlcNAc turnover plays a central role in the delicate regulation of the cardiovascular system. Therefore, the goals of this minireview are to summarize our current understanding of how changes in O-GlcNAcylation influence cardiovascular pathophysiology and to highlight the evidence that O-GlcNAc cycling is critical for normal function of the cardiovascular system.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acetilglucosamina / Sistema Cardiovascular / Proteínas Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acetilglucosamina / Sistema Cardiovascular / Proteínas Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article